Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

A proposal for the classification of sigma binding sites

Article Abstract:

A classification scheme for sigma binding sites is proposed based on data from biochemical and ligand-binding experiments. Important ligands used in distinguishing sigma subtypes include pentazocine and SK&F10047 which are specific for sigma 1 sites. Carbetapentane, dextromethorphan and phenytoin are sigma 1 selective ligands. Although haloperidol and DTG are the most used sigma ligands, they can not discriminate between sigma 1 and 2 receptors. Despite several biological functions attributed to sigma binding sites, specific functional roles of sigma 1 and 2 are unclear.

Author: Quirion, Remi, Bowen, Wayne D., Itzhak, Yossef, Junien, Jean Louis, Musacchio, Jose M., Rothman, Richard B., Tsung-Ping, Su, Tam, S. William, Taylor, Duncan P.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1992
Usage, Ligands (Biochemistry), Cell receptors, Binding sites (Biochemistry), Active sites (Biochemistry)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning

Article Abstract:

The role of central nervous system (CNS) chemokines and chemokine receptors in neuroinflammation and patterning has been reviewed. Chemokines are small proteins from 8 to 10 kDa involved in inflammatory-cell recruitment in the immune system. Chemokines and their receptors in the CNS are expressed at low levels in astrocytes, microglia and neurons. Their physiological function are facilitated by G protein-coupled receptors of the seven transmembrane domain, rhodopsin-type superfamily and have two main sites of interaction with their receptors.

Author: Quirion, Remi, De Souza, Errol B., Mennicken, Francoise, Maki, Rich
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1999
Inflammation, Central nervous system, Chemoreceptors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Any facts behind the DHEA hype?

Article Abstract:

Dehydroepiandrosterone (DHEA) cannot yet be classified as a 'superhormone' until its physiological significance and therapeutic use are established. The long-term prophylactic and therapeutic applications of DHEA must still be validated by clinical trials in large samples of aging individuals and in various age-related pathologies. Although it has been confirmed that serum levels of DHEAs decrease with age, there is yet no definitive evidence of a direct relationship between such declines and age-associated disorders in the elderly.

Author: Quirion, Remi, Bastianetto, Stephane
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1997
Aged, Elderly, Steroid hormones, Dehydroepiandrosterone

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Physiological aspects
Similar abstracts:
  • Abstracts: Evaluating claim substantiation data: separating marketing hype from reality. EEMCO worldwide in the new Millennium
  • Abstracts: AHA and exfoliative skin diseases. Reflections on skin care. The dry facts about wet perspiration
  • Abstracts: This and that: creatine's superfluous methyl and the shadowed art of Cimabue. This and that: the fire of Galileo's imagination and putting teeth into toxicology
  • Abstracts: The multiple applications of isotopic ratios. This and that: hair pigments, the hypoxic basis of life and the Virgilian journey of the spermatozoon
  • Abstracts: G protein regulation of adenylate cyclase. Receptor sites for Ca2+ channel antagonists. Direct regulation of cardiac Ca2+ channels by G proteins: neither proven nor necessary?
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.